Isomalt Market Outlook, Current and Future Industry Landscape Analysis 2031

Isomalt is anti-cariogenic, due to which it does not promote tooth decay. It is considered to have several health benefits, which is expected to spur isomalt sales. As per a study by Future Market Insights (FMI), the isomalt market is expected to surpass US$ 900.5 Mn in 2021.

Oral bacteria cannot convert isomalt into decay-causing acids easily. Thus, acidic condition that leads to demineralization does not develop after isomalt consumption, as compared to the one that occurs after eating normal sugar. Regulations by the Food and Drug Administration (FDA) allow manufacturers of sugar-free isomalt-based products to make health claim- ‘Does not support dental caries’ if those products do not reduce plague PH less than 5.7 upto 30 minutes after consumption. This safety property is fuelling the demand for isomalt.

Request a report sample to gain comprehensive market insights @

https://www.futuremarketinsights.com/reports/sample/rep-gb-2396

While isomalt have application across various industries, the beverages sector will account for maximum sales registered in the market. The demand from beverages sector is expected to rise at above 7% CAGR, sealing its dominance among end users between 2021 and 2031. Meanwhile, isomalt obtained from conventional sources will continue registering high sales, however, increasing focus on greater health benefits will tip scales in favour of organic isomalt.

Regionally, Europe will continue leading the market through the course of the forecast period. The presence of several leading manufacturers will give tailwinds to growth registered by the Europe market.

Key Takeaways from the Isomalt Market Study:

  • Despite a period of subdued growth amid COVID, isomalt market will continue expanding at a positive CAGR of 6.1% between 2021 and 2031
  • Rising incidence of diabetes has been spurring sales in the U.S., pushing it to account for nearly 90% of the North America market
  • While Europe continues dominating the global market, EU-4 countries will account for maximum isomalt sales through the forecast period
  • The U.K. will emerge as a highly lucrative market for isomalt, registering over 7% CAGR, after a period of decelerating isomalt sales in 2020
  • China will account for maximum shares of sales recorded in isomalt due to greater focus on health and wellness among consumers in the country

“Increasing applications of isomalt across diverse industries will result in market growth. In order to gain edge amid competition, manufacturers are launching new products with isomalt as a key ingredient. Isomalt is used to make various products such as confectionery, sugar confectionery, dairy products, bakery products, sports drinks, and others. Due to its low calorie content, isomalt is being increasingly used in various infant nutrition formulas and pharmaceutical products. .” Said a lead analyst at FMI

For Information On The Research Approach Used In The Report, Ask Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-2396

Plant-based Isomalt Gaining Popularity

Nowadays, people are inclined towards consumption of vegan products. According to SPINS report, U.S. retail sales of plant-based food grew 11.4% last year to US$ 5 Bn. People are shifting from use of animal products due to rising concerns, such as personal health and animal welfare. Isomalt is extracted from the plant sources such as beet, peaches, berries and hence is finding space in shelves of the consumers that are opting for plant-based diets and healthier food options.

Who is winning?

Some of the leading companies offering isomalt are BENEO GmbH, Cargill, Inc., Merck KGaA, Baolingbao Biology Co., Ltd., Akhil Healthcare Pvt Ltd, SINO Food Ingredients (SINOFI), KF Specialty Ingredients, Wilmar BioEthanol, Deiman SA de CV, Quadra Chemicals Ltd, S. A. Pharmachem Pvt. Ltd, and others

Manufacturers of isomalt are focusing on offering products through various online retailers to reach large consumer base. Food products are mainly perishable, and food and beverage products have to meet the quality expected by buyers and must comply with regulations. Isomalt, owing to its resistance to moisture, has a good shelf life. Therefore, it can be sold without deterioration. Making products easily available can boost the number of consumers purchasing a product. Several manufacturers are moving towards online channels with an aim to sell their products globally. This is helping them to increase their sales and growing their businesses.

Get Valuable Insights into Isomalt Market

Isomalt Market by Category

Nature

  • Organic Isomalt
  • Conventional Isomalt

Form

  • Powder Isomalt
  • Syrup Isomalt

End Use

  • Confectionery
  • Sugar Confectionery
  • Bakery Products
  • Breakfast Cereals & Bars
  • Dairy Products
  • Frozen Desserts
  • Beverages
  • Sports Drink
  • Meat & Fish Products
  • Infant Formula
  • Pharmaceuticals
    • Cough Syrups
    • Multivitamins
    • Supplements
    • Others
  • Oral Care
  • Others

Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Middle East and Africa (MEA)
  • Oceania

About Food Market Division at FMI

Expert analysis, actionable insights, and strategic recommendations – the food & beverage team at Future Market Insights helps clients from across the globe with their unique business intelligence needs. With a repertoire of over 1,000 reports and 1 million+ data points, the team has analysed the food & beverage industry lucidly in 50+ countries for over a decade. The team provides end-to-end research and consulting services; reach out to explore how we can help.

Telehealth Kiosk Market By Product, By Technology, By Application, By Region, And Segment Forecast 2022 – 2028

Telehealth kiosks are expected to become an essential part of a healthcare system and programs in the future. Telehealth kiosks allow health care professionals to treat patients at distance using telecommunication technology. Telehealth kiosk outfitted with telemedicine capabilities such as telephony and video conferencing with healthcare providers. Telehealth kiosk can lower healthcare costs to the patient and reduce visit and wait time. Telehealth kiosk has tools and capabilities such as store and forward diagnostic data and report. This capability of telehealth kiosk help to have access specialists anywhere. The systems have tools to track vital signs and other health data which is more beneficial for patients. Telehealth kiosk could reduce the number of transfer between one facility to another off-site medical facility which is helpful in reduce transportation cost and provide early diagnosis. Telehealth kiosk is designed to meet specific healthcare requirement in one in all solutions. Telehealth kiosk has features such as medical devices for clinical examination such as the stethoscope, Spo2 sensors, and blood pressure monitor. Telehealth kiosk is also available with special features such as ADA assistance devices for deaf, blind and limited mobility patients.

Request Sample Copy of Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-8327

Telehealth Kiosk Market: Drivers and Restraints

Increasing need of urgent care medical service expected to favor the demand for the telehealth kiosks. Technological advancement in the medical industry expected to impel the growth of telehealth kiosk market. Increasing demand for telehealth services in rural and urban areas in an advantage of minimum time duration is a major driving factor of telehealth kiosk market. Evolution and advancement in medical data transferring through telemedicine systems propel the growth of the telehealth kiosk market. Telehealth kiosks are gaining popularity in developed countries as high demand for healthcare cost reduction. Rise in partnership with manufacturers and hospital and pharmacies for telehealth kiosks are expected to favor the growth of the telehealth kiosk market.

Telehealth Kiosk Market: Overview

Telehealth kiosk is very helpful to provide healthcare facilities to rural and remote areas. Telehealth kiosk is beneficial for emergency and critical care situations, to provide access to healthcare services and reduce the cost of patient transfer. Telehealth kiosks are the better option for the overcome shortage of trained healthcare professionals and provide cost-effective medical consultation

Telehealth Kiosk Market: Key Market Participants: 

Example of some market players participants in global telehealth kiosk market identify across the value chain are American Well, Olea kiosks Inc., Computerized Screening Inc., H & S Quality in Software SpA, AMD Global Telemedicine, Inc., InTouch Health, Computerized Screening Inc., ZIVELO Inc., and others.

Ask from the Market Research Expert @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-8327

Market Overview

Telehealth kiosks are expected to become an essential part of a healthcare system and programs in the future. Telehealth kiosks allow health care professionals to treat patients at distance using telecommunication technology. Telehealth kiosk outfitted with telemedicine capabilities such as telephony and video conferencing with healthcare providers. Telehealth kiosk can lower healthcare costs to the patient and reduce visit and wait time. Telehealth kiosk has tools and capabilities such as store and forward diagnostic data and report. This capability of telehealth kiosk help to have access specialists anywhere. The systems have tools to track vital signs and other health data which is more beneficial for patients. Telehealth kiosk could reduce the number of transfer between one facility to another off-site medical facility which is helpful in reduce transportation cost and provide early diagnosis. Telehealth kiosk is designed to meet specific healthcare requirement in one in all solutions. Telehealth kiosk has features such as medical devices for clinical examination such as the stethoscope, Spo2 sensors, and blood pressure monitor. Telehealth kiosk is also available with special features such as ADA assistance devices for deaf, blind and limited mobility patients.

Telehealth Kiosk Market: Drivers and Restraints

Increasing need of urgent care medical service expected to favor the demand for the telehealth kiosks. Technological advancement in the medical industry expected to impel the growth of telehealth kiosk market. Increasing demand for telehealth services in rural and urban areas in an advantage of minimum time duration is a major driving factor of telehealth kiosk market. Evolution and advancement in medical data transferring through telemedicine systems propel the growth of the telehealth kiosk market. Telehealth kiosks are gaining popularity in developed countries as high demand for healthcare cost reduction. Rise in partnership with manufacturers and hospital and pharmacies for telehealth kiosks are expected to favor the growth of the telehealth kiosk market. In July 2018, Rite Aid Pharmacies signed a deal with California-based telehealth provider InTouch Health. Growing use of telehealth kiosk as the digital pharmacy is a major factor expected to boost the growth of telehealth kiosks market over the forecast period. Telehealth kiosks are able to administer the limited number of common medicines. Strong reimbursement policies for telemedicine carts have also favored the growth of telehealth kiosks market. However, the lack of trained manpower to support telemedicine and medical education expected to restrain the growth of the telehealth kiosks market.

Telehealth Kiosk Market: Overview

Telehealth kiosk is very helpful to provide healthcare facilities to rural and remote areas. Telehealth kiosk is beneficial for emergency and critical care situations, to provide access to healthcare services and reduce the cost of patient transfer. Telehealth kiosks are the better option for the overcome shortage of trained healthcare professionals and provide cost-effective medical consultation

Telehealth Kiosk Market: Region-wise Outlook

In terms of geography, the market has been divided into seven regions including North- America, Eastern Europe, Western Europe, and Asia- Pacific excluding & Japan (APEJ), Japan, Middle-East & Africa, and Latin America. North America is the most dominating market for telehealth kiosk market due to increasing partnership and investments in telemedicine sector and government initiatives for healthcare cost reduction. Western European expected to contribute second largest revenue share in telehealth kiosk market due to increasing adoption of telemedicine services, technology advancement, and increasing need for emergency consultation. The Asia Pacific excluding Japan telehealth kiosk market is expected to gain a high growth rate over the forecast period due to increasing healthcare spending and increasing digitalization. Increasing public-private partnership for the advancement of healthcare infrastructure, information technology, healthcare services expected to favor the growth of the APEJ telehealth kiosk market.

Telehealth Kiosk Market: Key Market Participants

Example of some market players participants in global telehealth kiosk market identify across the value chain are American Well, Olea kiosks Inc., Computerized Screening Inc., H & S Quality in Software SpA, AMD Global Telemedicine, Inc., InTouch Health, Computerized Screening Inc., ZIVELO Inc., and others.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain)
  • Eastern Europe (Poland, Russia)
  • Asia Pacific (India, China ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current, and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

Download PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-8327

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy

Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers, Dubai,

United Arab Emirates

MARKET ACCESS DMCC Initiative

For Sales Enquiries: sales@futuremarketinsights.com

For Media Enquiries: press@futuremarketinsights.com

Website: https://www.futuremarketinsights.com

Luciferase Assays Market Key Players – Life Technologies, Sigma Aldrich, Thermo Fisher, Promega, Clontech, Invivogen, Roche Applied Sciences

Luciferase Assays Market: Region-wise Outlook

In terms of geography, luciferase assays market has been divided into seven regions including North- America, Eastern Europe, Western Europe, Asia- Pacific excluding Japan, Japan Middle-East & Africa and Latin America. North America is expected to remain the dominating region while Asia Pacific is expected to emerge as a fastest growing region. Strong research funding and government to study newer assay methods makes North America the dominating region. Economically developing regions such as Asia Pacific has many companies focusing their resources in this region and trying to explore the luciferase assay market potential.

A bioluminescence experiment requires a paired set of biochemical: an enzyme named luciferase and a substrate, which is a molecule that emits light upon interacting with the enzyme or photoprotein. For each of the bioluminescent system required there is a unique co- factors and buffers that are required. Around us there are a lot of biological, natural and light producing systems which produces the enzyme named luciferases. The substrate of luciferases is coin as luciferins. Emil Heinrich DuBois-Reymond, a German physiologist coined both these terms. Luciferases and luciferins are both involved in totally different reactions. For instance, the most commonly used luciferase detects the biological energy molecule adenosine triphosphate.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-5565

Luciferase Assays Market: Drivers and Restraints

The market for luciferase assay is expected to upsurge owing to its penetrating usage in research to study the gene expression. Moreover, these luciferases has become powerful tool in molecular biology and genetic engineering where they have replaced chloramphenicol acetyltrans-ferase gene as a reporter. Bioluminescence is now filling its own niches as well as competing with chemiluminescence. ATP detection via firefly luciferase, for example, has no chemiluminescent counterpart. There is tremendous technological development in the luciferase assay market where the current luciferase technologies permit the quantitative visualization of gene expression at single-cell resolution by imaging its luminescence in real-time using a highly sensitive charged-coupled device (CCD) camera.

Luciferase Assays Market: Overview

These luciferases are used in bioluminescence assays as researchers believe that where there is light there would be ATP and measuring the light emitted while carrying out the bioluminescence assay is the measure of the metabolic activity. Today luciferases is used in all forms of testing to check the ATP. It is used to check the microbial contamination in many of the beverages company. There are a number of studies going on where the researchers link the interest gene with the luciferases to study the metabolic activity. The investigator through this linkage is able to follow gene expression at different stages of development in a transgenic organism.

Luciferase Assays Market: Key Market Participants

Some of the luciferase assays market participants are Life Technologies, Sigma Aldrich, Thermo Fisher, Promega, Clontech, Invivogen, Roche Applied Sciences, Switchgear Genomics, Origene, Perkin Elmer, EMD Millipore, Clontech, Gold Biotechnology, Lonza and GE Healthcare Life Sciences. New product launch, collaborations and acquisitions are few of the strategies the luciferase assays market players undertake. For instance, Promega Corporation introduced a new product named Nano-Glo Dual-Luciferase Reporter (NanoDLR) Assay, a two-reporter system that incorporates NanoLuc luciferase technology, providing increased data quality and greater sensitivity for biologically complex applications.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-5565

The report covers exhaust analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain)
  • Eastern Europe (Poland, Russia)
  • Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Luciferase Assays Market: Segmentation

On the basis of assay type the luciferase assays market can be segment as:

  • Beta-galactosidase (LacZ) assays
  • Luciferase assays
  • Fluorescent protein related assays
  • Chloramphenicol acetyltransferase (CAT) assays
  • Others

On the basis of application the luciferase assays market can be segment as:

  • Gene expression
  • Post-translational modification
  • Protein-protein interaction
  • Metabolic activity
  • Others

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance

For in-depth competitive analysis, Buy Now – https://www.futuremarketinsights.com/checkout/5565

Nanomaterials Market Size, Share | Industry Forecast Report 2025

The science of nanomaterials has created a lot of expectation amongst various end user industries. With the increasing applications of nanomaterials, the demand for it is increasing at an increasing rate and is becoming a part of daily lives. Nanomaterials are important product under the nanotechnology. They embrace nanoparticles, smaller than 100 nanometres in at least one dimension. Nanomaterials are widely used in healthcare, electronics, cosmetics and other areas nowadays. Continuous improvement and innovation in the field is driving the growth of the global nanomaterials market.

The extraordinary physical and chemicals properties of materials at the nanometre scale enable novel applications ranging from energy conservation and structural strength enhancement to antimicrobial properties and self-cleaning surfaces.  The nanotechnology is being increasingly modernised by expending largely on R&D activities which is resulting in the advancement of existing technologies and innovations with reference to the new materials.

Energy storage and construction market is providing a huge growth potential to these materials and driving the overall market for nanomaterials. The increasing electronics market is also providing opportunities to the global nanomaterials market due to the falling prices and improving materials property and efficiency.

Get a Sample Copy of Report:  https://www.futuremarketinsights.com/reports/sample/rep-gb-696

Nanomaterials Market: Drivers & Restraints

The market penetration of the already existing materials and ongoing development of new materials and applications is driving the global nanomaterials market. The unabated market for nanomaterials is being strongly supported by the governmental funding to support the potential growth. The increasing availability of several methods in the field of nanotechnology and new novel methods for fabricating the patterned nanostructures is offering opportunity for better modeling. Some of the other drivers for the growth of global nanomaterials market is partnerships & strategic alliances, increasing number of market players and newer material developments. One of the major factor restraining the growth of global nanomaterials market implies to the growing concerns over environmental impact and toxicity of nanomaterials.

 

Nanomaterials Market: Region-wise Outlook

The global nanomaterials market is expected to register a favourable growth for the forecast period, 2015?2025. North America and Europe are the two prominent regions that are projected to endure the control on the global nanomaterials market. Decreasing prices due to the increasing mass production is responsible for the robust growth of the above mentioned markets. The demand for nanomaterials is also surging across Asian regions. The Asia-Pacific region is projected to witness remarkable growth rate owning to the greater demand of nanomaterials in the developing regions like India and China and their continuous research and developmental activities.

Nanomaterials: Key Players

There are a lot of players in the nanomaterials industry of which some of the key market participants in global nanomaterials market are BASF, EMFUTUR Technologies, Evonik Industries, Sigma-Aldrich Co. LLC, Bayer AG, SkySpring Nanomaterials, Altair Nanotechnologies Inc., and Nanomaterials Company and others.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

Request Report Methodology:  https://www.futuremarketinsights.com/askus/rep-gb-696

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
  • Eastern Europe (Poland, Russia)
  • Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Ask Us Your Questions About This Report: https://www.futuremarketinsights.com/ask-question/rep-gb-696

 

Nanomaterials Market: Segmentation

On the basis of material type, the global nanomaterials market is segmented as follows:

  • Metal Oxide (Silica, Aluminium Oxide/Hydroxide, Titanium Dioxide, Zinc Oxide, Iron Oxide, Other Metal Oxides)
  • Metals
  • Chemicals and Polymers (Nanopharmaceuticals, Liposomes, Other Chemicals & Polymers)
  • Nanotubes
  • Others (Conventional Materials and New Materials)

On the basis of applications the global nanomaterials market is segmented as follows:

  • Construction
  • Packaging
  • Consumer Goods
  • Electrical and Electronics
  • Energy
  • Health Care
  • Transportation
  • Others

Non-Invasive Blood Glucose Monitoring Devices Market Size, Segmentation, Sales Channels, Type, Demand and Future Opportunities and Forecast 2022 – 2027

Diabetes has evolved as one of the primary healthcare epidemic characterized by high sugar levels and principle cause of mortality worldwide. In 2014, World Health Organization (WHO) estimated 8.5% of adults living with diabetes. A diabetic person cannot either synthesize enough insulin (type 1 diabetes) or either does not make enough insulin or cannot effectively use the insulin produced by the body (type 2 diabetes). Another type of diabetes that occur in women during her pregnancy is gestational diabetes. However, gestational diabetes is usually resolved after delivery but can precede towards type 2 diabetes later in a women’s life. Most of the continuous glucose monitoring devices are invasive and involves use of needles leading to increased chance of infection. Furthermore, the invasive glucose monitoring device is considered to be discrete glucose measurement system which cannot be practically used for continuous monitoring of blood glucose. Certain evidences of hyperglycemia between measurements are however not recorded thus resulting in false or no representation of the blood glucose pattern. Noninvasive monitoring of glucose levels eliminates the need of painful pricking with increased risk of infection, and amount of damage caused to the finger tissue.

Request Sample Copy of Report: @ https://www.futuremarketinsights.com/reports/sample/rep-gb-2613
Therefore, non-invasive continuous glucose monitoring devices are being widely investigated and studied over the past few years for their ability to monitor glucose continuously under highly controlled (e.g. in-clinic) conditions. Various techniques that involves measurement of blood glucose levels non-invasively includes, Near Infrared Spectroscopy (NIRS), Mid -Infrared Spectroscopy (Mid-IRS), Raman Spectroscopy, Photo-acoustic Spectroscopy (PA), Optical Coherence Tomography (OCT) and many more.
Non- Invasive Blood Glucose Monitoring Devices Market: Overview 

Rising prevalence of diabetes worldwide imposes significant economic consequences on the individual’s life. Currently, there are 350 million people worldwide estimated to live with diabetes. Thus continuous monitoring of blood glucose levels is essential in order to manage the ever increasing prevalent population living with diabetes currently. For this reason manufacturers are focusing on developing diagnostic techniques that are highly reliable and monitors individual’s blood glucose levels with greater accuracy with the capability to improve glycemic control and patient wellbeing. By integration of sensing elements, electronics along with a reliable power source in a single unit, noninvasive blood glucose monitors are offering immense opportunity for all the device manufacturers along with patients and various healthcare providers across the world. Accelerated regulatory approvals of blood glucose monitors is one of the another important factor leading to increased revenues of noninvasive blood glucose devices over the forecast period.

Non- Invasive Blood Glucose Monitoring Devices Market: Key Players
Some of the key market players in the non- invasive blood glucose monitoring devices market include:
  • Abbott,
  • Animas Technologies,
  • Bayer Healthcare,
  • Cercacor,
  • Pendragon Medical,
  • OrSense, and Bayer Healthcare.

Ask from the Market Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-2613

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications. 

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
Market Size
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Value Chain

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
  • Eastern Europe (Poland, Russia)
  • Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan

Middle East and Africa (GCC, S. Africa, N. Africa)

Buy this report @ https://www.futuremarketinsights.com/checkout/2613

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Pharma and Healthcare Social Media Marketing Market Key Players – Digital Healthcare, Sermo, MomMD, Student Doctors Network, QuantiaMD, Doximity

Pharma and healthcare social media marketing is an area that is extremely relevant to the modern, digital age, where stakeholders in the pharmaceuticals and healthcare industries are reaching out to their potential customers through digital, social media platforms.Social media tools today enable one-to-one interactions among stakeholders and their target customers via content creation, sharing, along with exchange of new ideas and information about products through virtual communities and social networks.

The global market for pharma and healthcare social media marketing services is booming in the information age, as almost all the stakeholders in the pharma and healthcare industries are emerging in the world of social media to market their products, mainly because their potential customers are spending most of their time on social media.

Though social media tools are proving highly effective for the marketing of pharma and healthcare products in the world of customer-centric business, their use is still a matter of debate among end users.

Nevertheless, the overall growth of the global market for pharma and healthcare social media marketing services is expected to witness astonishing growth in the coming years, as a majority of businesses are taking their operations digitally.

Leading players in the market are increasing their focus on crafting creative marketing campaigns to help their customers gain a competitive advantage through more effective interaction and engagement with their target audience consistently.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-403

Social Media Marketing Strategies to Help Strengthen Customer Relationship

Leading players in the pharmaceuticals and healthcare sector have always been experimenting with innovative ways to expand their customer base and gain a competitive advantage, while there are multiple restrictions on the advertising and marketing of pharmaceuticals and medical products.

However, social media platforms have emerged as a useful tool for pharma and healthcare companies to implement effective marketing campaigns that can give amplified results to their efforts of improving engagement, expanding their customer base, and ultimately, dramatically boosting the brand performance in global markets.

Global leaders in the pharmaceuticals and healthcare markets are leveraging the modern social media platforms to establish a new brand identity and creating brand awareness among their existing as well as potential customer bases.

This enables them to create a personal bond with each one of their audience on social media, which further strengthens their customer relationship management operations, and it is expected to further highlight the importance of social media marketing among pharma and healthcare companies in the coming years.

In addition to this, social media marketing is also giving a completely different perspective to pharma and healthcare marketing, as it can also contribute to the end users’ efforts not only in building but also in improving corporate communication and investor relations. It has also helped them improve their customer services even on corporate levels through the implementation of creative social media marketing campaigns.

Involvement of Regulatory Bodies may Restrict the Scope of Social Media Marketing for Pharma and Healthcare Companies

The pharma and healthcare sector is subjected to various rules and regulations regarding the marketing of medical and pharmaceutical products, and this scenario also follows in the planning of social media marketing strategies for these companies.

Governing bodies are modifying their traditional regulatory restrictions on the advertising of drugs and other marketing innovations in the pharma and healthcare industries.

Involvement of regulatory bodies in the global market for pharma and healthcare social media marketing is mainly in the areas of crafting and issuing guidelines in advertising of drugs and biologists through interactive media.

Various policies along with laws and regulations play an instrumental role in deciding the importance and effectiveness of social media in the marketing of pharma and healthcare products, though it restricts the scope of marketing campaigns.

For instance, the United States Food and Drug Administration (FDA) released new guidelines in January 2014, for the pharmaceuticals and healthcare industries defining the regulatory requirements vis-a-vis the marketing submissions for human and animal drugs across social media platforms.

Through its draft, the FDA also clarified various guidelines for content creators and marketers working in the pharmaceutical and healthcare marketing industry while working on the dissemination of branded information about drugs and biologics.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-403

Pharma and Healthcare Social Media Marketing Market: Region-wise Analysis

Based on the geographical factors, the pharma and healthcare social media marketing market is broadly divided into seven regions – North America, Latin America, Europe, East Asia, South Asia, Oceania, and Middle East & Africa.

Though the social media marketing industry has defied all the norms of geographical boundaries, the growth of the  pharma and healthcare social media marketing market is expected to remain significantly high in developed countries – mainly in the United States of America.

With the increasing number of pharma and healthcare companies making a tectonic shift from traditional marketing platforms to social media platforms, the demand for  pharma and healthcare social media marketing services is increasing in North America.

A mounting number of digital marketing agencies are jumping to grab the lucrative opportunities in the North American market for  pharma and healthcare social media marketing.

North America, followed by Europe, is expected to account for a significantly high revenue share in the global pharma and healthcare social media marketing market. However, the digital marketing industry in Asia Pacific is booming with the increasing awareness about social media and growing number of social media users in developing Asian countries – especially in China and India.

Emerging players in the Asia Pacific pharma and healthcare social media marketing market are expected to gain a competitive edge with the use of creative marketing campaigns along with the favourable regulatory environment in the region.

Pharma and Healthcare Social Media Marketing Market: Competitive Landscape

  • Digital Healthcare
  • Sermo
  • MomMD
  • Student Doctors Network
  • QuantiaMD
  • Doximity
  • Healthcare and Medical Software
  • Orthomind
  • WeMedUp
  • Medical Apps
  • DoctorsHangout
  • Nurse Zone
  • All Nurses
  • Medical Doctors
  • Ozmosis

Other pharma and healthcare companies that are highly engaged in social media marketing include Novartis, Johnson & Johnson, Pfizer, Inc., Novo Nordisk, and Bayer AG.

Region-wise Analysis

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil)
  • Europe (Germany, U.K., France, Italy, Spain, Poland, Russia)
  • East Asia (China, Japan, South Korea)
  • South Asia (India, Thailand, Malaysia, Vietnam, Indonesia)
  • Oceania (Australia, New Zealand)
  • Middle East & Africa (GCC Countries, Turkey, Northern Africa, South Africa)

Report Highlights

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

For in-depth competitive analysis, Buy Now – https://www.futuremarketinsights.com/checkout/403 

Pharma and Healthcare Social Media Marketing Market: Segment Analysis

The pharma and healthcare social media marketing market can be segmented on the basis of the following:

By Social Media Platform

  • Youtube
  • Twitter
  • Instagram
  • Facebook

By End User

  • Healthcare Professionals
  • Hospitals
  • Biotechnology Companies
  • Patients/Consumers

Respiratory Inhaler Devices Market Key Players- AstraZeneca, Beximco Pharmaceuticals Ltd., Boehringer Ingelheim GmbH, Cipla Ltd., GlaxoSmithKline plc.

Global respiratory inhaler device shipments are likely to grow at over 4% in 2021, as the medical device industry makes a gradual recovery. Innovation in smart inhaler technologies is likely to be a key focus area, but manual inhalers will still account for 90% of total demand. This stark contrast reflects the status-quo in the global medical device industry, where realization of new investment and bottom-lines are concurrent.

[250 Pages Report] The rising prevalence of respiratory disorders has necessitated innovation in manufacture of respiratory inhalers. The demand for better precision in drug delivery is enabling broader adoption of Respiratory Inhaler Devices, especially among patients of asthma and chronic obstructive pulmonary diseases (COPD). Steady growth is expected to continue as favorable reimbursement policies by governments create a conducive environment around the world.

Global demand for respiratory inhaler devices continues to be driven by rising prevalence of COPD and asthma. According to the World Health Organization (WHO), nearly 251 million cases of chronic obstructive pulmonary disease (COPD) were reported worldwide in 2016 and nearly 339 million people were estimated to have asthma in the same year. Coupled with this, surging healthcare spending has been creating lucrative prospects for growth of the market.

Market players also are focusing on novel inhalation technologies to ascertain drug delivery to lungs. Spurred by these factors, the global market for respiratory inhaler devices is expected to report surging sales.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-493

Smart Inhaler Technology Touted as a Major Breakthrough

Smart inhalers have been touted as a disruptive technology, and it remains a key focus area for manufacturers. Smart inhalers can signal patients if their overusing any medication, warning them against poor management of the condition. The technology is touted as a major breakthrough in the healthcare sector and one that is expected to enable growth in the respiratory inhaler devices market in the coming years.

Several studies already are underway gauging the potential of these development. For instance, My AirCoach, which is an EU-funded multi-institutional research project, aims at assessing how novel mobile health technologies, including smart inhalers, can help offering improved asthma control.

With myriad of developments underway, respiratory inhaler device shipments are likely to gain traction through 2030. FMI’s report offers a comprehensive analysis on how growth will unfold. Some of the key takeaways from the report are:

  • Dry powder inhalers remain the most lucrative category
  • Manually operated inhaler devices will remain preferred choice among available technologies
  • Respiratory inhaler devices sales surging to offer improved asthma control and management
  • US to remain a highly lucrative market for respiratory inhaler devices, however, growth in East Asia is expected to accelerate at a higher pace

“Some of the leading players are working on technologies that would enable monitoring and correction of inhalation techniques in the near future. They are developing smart inhalers that will use the Bluetooth technology to monitor inhaler use in patients. While several developments are underway, industry experts are cautiously examining the potential of smart inhalers to ensure all potential concerns pertaining to the novel technologies are ironed out. However once launched, smart technology can help the market gain momentum at accelerated pace in the near future,” said a lead analyst at FMI.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-493

Some of the leading companies are focusing on innovations and product launches to gain competitive advantage. There also are companies trying to capitalize on opportunities across high potential markets. For instance, Zydus Cadila has announced launching India’s first pressurized Metered Dose Inhaler (pMDI) – Forglyn pMDI with a combination of Long Acting Beta Agonist (LABA) and Long Acting Muscarinic Antagonist (LAMA) for COPD patients in October 2020.

In 2019, Lupin announced launching “ADHERO,” which is a connected smart device for metered dose inhalers and promises to ensure improved adherence to inhalation therapy for COPD treatment.

In the latest report by Future Market Insights, we offer an unbiased analysis of the global respiratory inhaler devices market, providing historical data for the period of 2015-2019 and forecast statistics for the period of 2020-2030. In order to understand the global market potential, its growth and scopes, the market is segmented on the basis of product type (dry powder inhaler, metered dose inhaler, and nebulizer), technology (manually operated inhaler devices and digitally operated inhaler devices), disease indication (asthma, COPD, pulmonary arterial hypertension, other respiratory diseases), across six major regions (North America, Latin America, Europe, South Asia, East Asia, Oceania, MEA).

Key Segments

Product

  • Dry Powder Inhalers
  •  Metered Dose Inhalers
  • Nebulizers
    • Compressed Air Nebulizers
    • Ultrasonic Nebulizers
    • Mesh Nebulizers

Technology

  • Manually Operated Inhaler Devices
  • Digitally Operated Inhaler Devices

Disease Indication

  • Asthma
  • Chronic Obstructive Pulmonary Disease
  • Pulmonary Arterial Hypertension
  • Others

For in-depth competitive analysis, Buy Now – https://www.futuremarketinsights.com/checkout/493

Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Middle East and Africa (MEA)
  • Oceania

U.S. Compounding Pharmacies Market is expected to grow at over 5.1% CAGR between 2022 and 2028

[81 Pages Report] According to a recent research by Future Market Insights (FMI), the global compounding pharmacies market is estimated to have accounted around US$ 8 Bn in terms of value during 2022. The report on the U.S. compounding pharmacies market also projects that the market will grow at a CAGR of approximately 5% during the period 2022-2028.

The U.S. compounding pharmacies market revenue is expected to increase at a robust growth rate over the next few years despite the reporting of several adverse events and drug mismanagement-related deaths. The U.S. compounding pharmacies market is expected to gain popularity in several regions of the U.S. due to upcoming products and therapeutic areas that are yet to be tapped by branded manufacturers.

Focus on factors, such as the availability of drugs in innovative medium/forms and the administration of varying dosages for various indications, is expected to drive the adoption of newer dosage forms of compounded medications.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-978

Market Remains Influenced by Availability of Compounded Pain Management Drugs

The growing popularity of pain management therapies is fuelling the growth of U.S. compounding pharmacies market. Compounded pain management drugs are not FDA-approved, however, they come under the State Pharmacies Board supervision in the U.S.

For example, medical guidelines such as the Chronic Pain Guidelines stated by the Medical Treatment Utilization Schedule (MTUS) do not support the use of compounds such as Gabapentin and Baclofen for pain management. However, compounding pharmacies use these compounds as well as several others in varying strengths to attract customers and increase their revenue.

Moreover, an increase in the shortage of prescription medicine is expected to upsurge the demand for compounding pharmacies. According to the U.S. FDA, only 154 drugs were in short supply or not available in 2007, as compared to 456 in 2012.

Currently, the number of drugs in short supply is around 300. Medicinal drought is prominent in the U.S. as compared to other countries, which is also fuelling the revenue growth of the U.S. compounding pharmacies market.

On the other hand, increasing regulatory pressures are expected to hamper the growth of the U.S. compounding pharmacies market. Compounding pharmacies are engaged in trans-boundary drug compounding, and the manufacturing of bulk drugs & ingredients need to be registered with the FDA, undergo mandatory inspections, and abide by GMP guidelines.

For instance, the FDA has stated that around 70% of registered firms have been inspected, of which 28 firms have been issued FDA Form 483s (non-adherence to cGMP regulations and unsafe compounding practices), and five warning letters, which implies a very high rate of action.

Compounding pharmacies registering with the FDA could serve to increase credibility. However, inspections and compliance with good manufacturing practices is compulsory. Regulatory pressures on compounding pharmacies are expected to force the smaller ones to close their business primarily due to unsafe compounding practices, which are likely to directly impact patient safety.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-978

Hormone Replacement Therapeutic Area to Hold over 38% Revenue Share in Market

By product type, oral medication is the expected to dominate the U.S. compounding pharmacies market in term of revenue, which is then followed by topical medication. The injectable segment by product type of the U.S. compounding pharmacies market is projected to grow at a significant rate as compared to other segments.

The hormone replacement therapy segment is the leading segment in terms of revenue among all the therapeutic area segments of the U.S. compounding pharmacies market, and is estimated to gain a 38.4% revenue share in 2022.

Among the pharmacy type segments, the 503A pharmacy segment is expected to gain a major revenue share as compared to the 503B pharmacy segment over the forecast period. By application, the adults segment is estimated to dominate the U.S. compounding pharmacies market, followed by the paediatrics segment.

The veterinary segment is expected to grow at a faster pace as compared to the other application segments of the U.S. compounding pharmacies market.

The U.S. compounding pharmacies market report tracks some of the key companies operating in the market, which include Avella Specialty Pharmacy, Central Admixture Pharmacy Services, Inc., Fagron N.V., Wedgewood Pharma, PharMEDium Services LLC, Doughertys Pharmacy, Institutional Pharmacy Solutions, Lorraine’s Pharmacy, Village Compounding Pharmacy, Triangle Compounding Pharmacy, Olympia Pharmacy, Hoye’s Pharmacy, Vertisis Custom Pharmacy, Smith Caldwell Drug Store, AIS HealthCare, Soleo Health, Millers Pharmacy, Centene Corporation, Infinity Care Solutions, Triumph Pharmacy, and Sixth Avenue Medical Pharmacy.

U.S. Compounding Pharmacies Market By Category

By Product :

  • Oral Medication
    • Solid Medication
      • Capsules
      • Tablets
      • Mixtures
      • Lollipops
      • Lozenges
    • Liquid Medication
      • Syrup
      • Solution/li>
      • Emulsion
      • Suspension
    • Topical Medication
      • Gels
      • Ointments
      • Creams
      • Lotions
  • Injectable
  • Mouthwashes
  • Nasal
  • Ocular
  • Otic
  • Suppositories and Enemas

By Pharmacy Type :

  • 503A Pharmacy
  • 503B Pharmacy

By Application :

  • Adults
  • Pediatrics
  • Geriatrics
  • Veterinary

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-978

By Therapeutic Area :

  • Hormone Replacement Therapy
  • Pain Management
  • Dermatology
  • Oncology
  • Hematology
  • Dental
  • Others

General Anesthesia Drugs Market is expected to grow at a CAGR of ~3% during the forecast period of 2022-2029

A new study of Future Market Insights (FMI) indicates that the global general anesthesia drugs market is poised for steady growth in the years ahead. Today, the general anesthesia drugs market remains driven by increased proportion of elderly patients and rising volume of surgical procedures; FMI analyst forecasts the market to witness 3.5% CAGR during the period, 2019-2029.

According to the FMI analyst, worldwide sales of general anesthesia drugs will increase ~3% year-over-year to total ~US$ 4.3 billion in 2019, up from US$ 4.17 billion in 2018. The analyst identifies growth opportunities in the development of new drugs that can overcome shortcomings such as adverse effects, procedural complications and allergic reactions.

As the development of ultra-short acting hypnotic or sedative agent without adverse effects remains an unfulfilled dream, a search for newer drugs and clinical trials of formerly withdrawn drugs to remove the undesirable effects while maintaining their beneficial effects have been underway. Collaborating with research institutes to understand the challenges in designing and developing effective drugs will continue to be a key focus area of manufacturers as well.

Propofol IV Drugs Continue to Witness Significant Adoption

Relatively high adoption of propofol intravenous drugs in large number of surgeries performed globally continues to influence growth strategies, which accounted for ~25% revenue share in 2018.

“While many anesthesiologists prefer the use of propofol for its lipophilic nature and rapid onset of action on the body, water soluble formulations of propofol are being developed to address the disadvantages associated with lipid formulations such as hyperlipidemia, pain on injection, and bacterial growth,” said the FMI analyst.

The FMI analyst predicts the sales of inhalation anesthetics such as sevoflurane to be valued at ~US$ 830 million in 2019, while the sales of desflurane is likely to increase 2.5% in that year. On the one hand, midazolam and remifentanil continue to represent the lowest revenue shares in the market.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-388

Adoption in Ambulatory Surgical Centers to Ramp up in 2019

General anesthesia drugs worth US$ 1.8 billion were sold in hospitals in 2018, driven by rising number of hospitals along with the emergence of favorable reimbursement policies across the globe.

“A notable increase in ambulatory surgeries and rising utilization of general anesthesia drugs for outpatient procedures have been significantly contributing to the market growth,” said the FMI analyst.

In 2018, general anesthesia drugs sold in ambulatory surgical centers totaled a revenue worth ~US$ 1.4 billion, and is estimated to record 3% high in 2019.

North America, Europe, and East Asia Markets in the Vanguard

North America continues to acquire the leading position in general anesthesia drugs market, accounting for a 30% revenue share in 2018 total, followed by Europe and East Asia.

The FMI analyst anticipates a rising number of complexity of medical interventions requiring induction and maintenance of general anesthesia drugs in several nations in Europe, driven further by an ongoing aging of population. Sales in the region are likely to exhibit a CAGR of 3% during the forecast period.

East Asia (24% share) will continue to greater opportunities for the market players, in the view of rising approvals of drugs along with favorable government initiatives for the development of healthcare infrastructure.

“Although the demand for general anesthesia drugs directly correlates with the advancements in complex surgeries, manufacturers will need to direct their investments towards R&D for safer drugs, considering the uncertain study results relative to the impact of general anesthesia drugs on developing as well as aging brain,” said the FMI analyst.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-388

GENERAL ANESTHESIA DRUGS MARKET TAXONOMY

The global general anesthesia drugs market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

By Drug Class

  • Propofol
  • Sevoflurane
  • Dexmedetomidine
  • Desflurane
  • Remifentanil
  • Midazolam
  • Others
  • (Others – Sufentanil, Fentanyl, Ketamine, Isoflurane, Thiopental etc.)

By Route of Administration

  • Intravenous Anesthesia
  • Inhaled Anesthesia

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

For in-depth competitive analysis, Buy Now – https://www.futuremarketinsights.com/checkout/388

By Region

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • MEA

Automated Breast Ultrasound System Market is slated to grow at approximately 10% CAGR during the forecast period 2022 – 2031

Rising prevalence of breast cancer across the globe and increasing government initiatives undertaken to encourage breast cancer awareness have significantly fuelled the demand for automated breast ultrasound system, according to ESOMAR-certified Future Market Insights’ (FMI) latest research report. As per the study, the global automated breast ultrasound system market is slated to grow at approximately 10% CAGR over the forthcoming decade.

Key manufacturers are actively focusing on developing faster, accurate and minimal invasive ultrasound breast imaging system. According to report published in National Library of Medicine, integration of mammography with automated breast ultrasound system increased the sensitivity of the system to 99.1%.

The combination drastically improves cancer detection rate among dense breasted women and reduces the interpretation time. Prominent manufacturer GE Healthcare launched a new automated breast ultrasound system named “Invenia” in U.S in October 2018. The main function of the system is to identify the presence of mammographically occult cancer especially in women with dense tissues.

With various other developments on cards, the automated breast ultrasound system market is expected to showcase impressive growth between 2021 and 2031.

To remain ‘ahead’ of your competitors, request for a sample

Key Takeaways from FMI’s Automated Breast Ultrasound Systems Market Study

Increasing government investment to promote breast cancer awareness among women will bolster demand across the U.S.

The U.K is expected to experience noteworthy growth as governments and private organizations aim at curbing high mortality rate due to breast cancer.

Presence of modern healthcare infrastructure will increase automated breast ultrasound system adoption across Germany

Saudi Arabia will offer lucrative opportunities owing to rapid urbanization and emergence of advance diagnostics centers.

India is expected to exhibit increasing demand owing to increase in per capita income and to growing incidence of breast cancer among women.

Hospitals are expected to lead the market driven by faster accessibility modern tool and availability of skilled professionals.

“Visibly rising consumer inclination towards radiation free imaging and diagnostics systems is likely to intensify sales of automated breast ultrasound system among diagnostics laboratories,” says the FMI analyst.

Competitive Landscape

GE Electric Co., Siemens A.G., Hitachi Ltd., SonoCiné Inc., Koninklijke are some prominent players operating in the automated breast ultrasound system market. They are focusing on improving the accuracy of automated breast ultrasound system for faster assessment of cancer screening in addition to getting government approval for their products.

For instance, Hitachi being the global leader in smart life & eco-friendly systems launched its latest automated breast ultrasound system “SOFIA” capable of scanning and acquiring image of the complete breast.

Koninklijke launched Philips EPIQ and Affiniti ultrasound systems as a part of its automated breast ultrasound system product range. Philips EPIQ is laced with an integrated eL18-4 transducer and employs anatomical intelligence for accurate imaging of the breast with high tissue density.

Key Points Covered

Market estimates and forecast 2015-2031

Key drivers and restraints impacting market growth

Segment-wise, Country-wise, and Region-wise Analysis

Competition Mapping and Benchmarking

Brand share and Market Share Analysis

Key Product Innovations and Regulatory Climate

COVID-19 Impact on Automated Breast Ultrasound System Market and How to Navigate

Recommendation on Key Winning Strategies

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-606

Key Segments Covered

 

By End User

Hospitals

Diagnostic Imaging Laboratories

Region

North America

U.S.

Canada

Latin America

Brazil

Mexico

Argentina

Rest of Latin America

Western Europe

EU-5

BENELUX (Belgium, Netherlands, Luxembourg)

NORDIC (Denmark, Finland, Iceland, Norway, Sweden)

Rest of Europe

Eastern Europe

Poland

Russia

Rest of Eastern Europe

Japan APEJ (Asia Pacific excluding Japan)

China

India

ASEAN Countries

Australia & New Zealand

Rest of APEJ

MEA

GCC Countries

South Africa

Israel

Turkey

Iran

Rest of Middle East & Africa

For in-depth competitive analysis Buy Now – https://www.futuremarketinsights.com/checkout/606

About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com/